NASDAQ$CYPH

Cypherpunk Technologies Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Cypherpunk Technologies reported Q2 2025 a net loss of $8.0M, diluted EPS of $-0.15.

For Q2 2025, Cypherpunk Technologies reported net loss was $8.0M, diluted EPS was $-0.15. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Net loss $8.0M.
  • Diluted EPS $-0.15.
  • MD&A highlights operating priorities, capital, and sector risks.

Headline financials

Total Revenue

$0.00

No prior period
EPS (adj)

-$0.15

No prior period
R&D Expenses

$10.5M

No prior period
G&A Expenses

$1.82M

No prior period
Total OpEx

$16.9M

No prior period
Interest Income

$246K

No prior period
AUS R&D Incentive

$1K

No prior period
FX Gain

-$2K

No prior period
Net Income

-$8M

No prior period
Operating Income

-$16.9M

No prior period

Revenue & EPS history

Leap Therapeutics · Revenue · Quarterly

$0

Q2 2025
Beat estimate in 2 of 3 quarters(67%)
ActualEstimate

Forward guidance

Outlook emphasizes path to profitability, liquidity, and cost discipline.

Tailwinds

  • Operating initiatives and partnership milestones.
  • Cash runway and restructuring progress.

Headwinds

  • Operating losses and financing needs.
  • Competitive and regulatory uncertainty.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

+11.8%

Avg return

Earnings day

+13.6%

Avg return

5 days after

+11.4%

Avg return

30 days after

50%

17 / 34 earnings

Positive

+389.9%

Q3 2025

Best reaction

-44.0%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2025+389.9%+454.8%+228.8%
Q2 2025-28.3%-15.6%-11.8%
Q1 2025-2.5%-12.4%-0.5%
Q4 2024+16.9%-21.4%+3.1%
Q3 2024-11.1%-14.5%-9.2%
Q1 2024-1.1%-5.4%-22.1%
Q4 2023-0.5%+14.0%+35.7%
Q3 2023+13.0%+32.6%+128.3%
Q2 2023+7.6%-8.9%-28.4%
Q1 2023+17.1%+44.4%+44.4%
Q4 2022-12.1%-0.9%+11.5%
Q3 2022+12.0%-3.2%-17.7%
Q2 2022+10.0%-0.8%+30.0%
Q1 2022+34.6%+25.4%+10.0%
Q4 2021-8.6%+2.3%+0.0%
Q3 2021+0.4%+0.8%+2.9%
Q2 2021+0.6%+3.6%-12.0%
Q1 2021+9.5%+8.8%+21.6%
Q4 2020+7.9%+6.1%-21.1%
Q3 2020+0.6%-3.1%+21.4%
Q2 2020-3.1%+0.3%-5.6%
Q1 2020+0.0%+0.4%+3.1%
Q4 2019-4.1%-14.2%+20.3%
Q3 2019-44.0%-33.7%-29.7%
Q2 2019-8.9%-10.2%+2.5%
Q1 2019-1.6%-6.5%-0.6%
Q4 2018+10.7%+4.3%-9.1%
Q3 2018-8.8%-17.1%-26.8%
Q2 2018+2.1%+6.1%+8.7%
Q4 2017-1.4%+1.2%+30.8%
Q3 2017-2.1%+16.9%+9.2%
Q2 2017-5.6%+2.0%-6.2%
Q1 2017+8.6%+10.4%-8.9%
Q4 2016+4.0%-4.7%-16.2%
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro